| ID LINK | NAME | STRUCTURE CAS | CLOGP | CLOGS | MW | THERAPEUTIC AREA |
|---|---|---|---|---|---|---|
| FDBD00200 | Capreomycin |
 11003-38-6 |
-5.831 | -2.429 | 668.706 | Used in the treatment of tuberculosis in combination with other drugs. |
| FDBD00201 | Zolmitriptan |
 139264-17-8 |
2.772 | -4.278 | 287.357 | For the acute treatment of adult migraine with or without auras. |
| FDBD00202 | Acetaminophen |
 103-90-2 |
0.887 | -1.586 | 151.163 | For temporary relief of fever, minor aches, and pains. |
| FDBD00203 | Gefitinib |
 184475-35-2 |
4.309 | -7.031 | 446.902 | For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies. |
| FDBD00204 | Codeine |
 76-57-3 |
1.859 | -2.461 | 299.364 | For treatment and management of pain (systemic). It is also used as an antidiarrheal and as a cough suppressant. |
| FDBD00205 | Piperacillin |
 66258-76-2 |
-0.686 | -2.005 | 517.555 | For the treatment of polymicrobial infections. |
| FDBD00206 | Dihydroergotamine |
 511-12-6 |
2.099 | -5.264 | 583.677 | For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. |
| FDBD00207 | Amitriptyline |
 50-48-6 |
4.858 | -5.482 | 277.403 | For the treatment of depression, chronic pain, irritable bowel syndrome, sleep disorders, diabetic neuropathy, agitation and insomnia, and migraine prophylaxis. |
| FDBD00208 | Floxuridine |
 50-91-9 |
-0.074 | -0.189 | 246.192 | For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. Also for the palliative management of liver cancer (usually administered by hepatic intra-arterial infusion). |
| FDBD00209 | Tolcapone |
 134308-13-7 |
1.825 | -3.199 | 273.241 | Used as an adjunct to levodopa/carbidopa therapy for the symptomatic treatment of Parkinson's Disease. This drug is generally reserved for patients with parkinsonian syndrome receiving levodopa/carbidopa who are experiencing symptom fluctuations and are not responding adequately to or are not candidates for other adjunctive therapies. |
2911 ,
292
